BHMP
SAGE

Bardin Hill Management Partners’s Sage Therapeutics SAGE Stock Holding History

Bardin Hill Management Partners’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-121,519
Closed -$1.11M – 21
2025
Q2 		$1.11M Buy
+121,519
New +$894K 0.65% 21

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Bardin Hill Management Partners's SAGE Position: Q3 2025 in Review

Bardin Hill Management Partners sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 121,519 shares — an estimated $1.11M sold.

Bardin Hill Management Partners first reported a position in SAGE in Q2 2025 and held it in 1 quarter. The position peaked at $1.11M in Q2 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Bardin Hill Management Partners reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Bardin Hill Management Partners sold 121,519 Sage Therapeutics shares in Q3 2025, an estimated $1.11M.
  • Bardin Hill Management Partners first reported a position in Sage Therapeutics in Q2 2025 and held it in 1 quarter.
  • Bardin Hill Management Partners's Sage Therapeutics position peaked at $1.11M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Bardin Hill Management Partners's 13F filing for Q3 2025, filed 12 Nov 2025.